アルブミン賦形剤の世界市場レポート 2024年

アルブミン賦形剤市場規模は近年力強く成長しています。2023年の45億6,000万米ドルから2024年には49億1,000万米ドルまで、CAGR7.6％で拡大します。過去数年間に見られた成長は、バイオ医薬品産業の拡大、生物製剤の採用拡大、慢性疾患の有病率の上昇、臨床実践と医薬品イノベーションの進歩、ドラッグデリバリーへの注目の高まりなど、いくつかの要因によるものです。

慢性疾患の有病率の増加は、今後のアルブミン賦形剤市場の成長を牽引するものと思われます。慢性疾患は、3ヵ月以上持続し、時間の経過とともに悪化する可能性があることが特徴であり、より一般的になってきています。アルブミンは、血漿中に最も豊富に存在する循環タンパク質として認識されており、血液の増量剤として機能し、がんや糖尿病を含む様々な疾患の治療において重要な役割を果たしています。その多用途な性質は、薬物ターゲティングのための理想的なタンパク質担体となり、ペプチドまたはタンパク質ベースの薬物の薬物動態プロファイルの強化に貢献します。米国連邦政府が運営する国立医学図書館であるThe National Center for Biotechnology Informationの2023年1月のデータによると、米国の50歳以上で少なくとも1つの慢性疾患を持つ人の数は99.5％増加し、2020年の7,152万2,000人から2050年には1億4,266万人になると予測されています。このため、慢性疾患の蔓延がアルブミン賦形剤市場の成長促進要因となっています。

また、ヘルスケア支出の増加も、当面のアルブミン賦形剤市場の拡大に大きく寄与すると予想されます。ヘルスケア支出には、保健サービス、家族計画活動、栄養プログラム、および健康に主眼を置いた緊急支援活動の提供に関連するすべての費用が含まれます。ヘルスケア支出の増加傾向はアルブミン賦形剤市場にプラスの影響を与え、医薬品やバイオ医薬品における高度なアルブミン製剤の開拓と活用に大きな財政的支援を提供します。米国の連邦機関であるメディケア＆メディケイドサービスセンターが2023年6月に報告したように、米国の医療費は2.7％増加し、2021年には1人当たり1万2,914米ドルに相当する総額4兆3,000億米ドルに達しました。これは国内総生産の18.3％を占める。したがって、ヘルスケア支出の増加は、アルブミン賦形剤市場の成長を促進する重要な要因として浮上しています。

2023年のアルブミン賦形剤市場で最大の地域は北米でした。アジア太平洋は、予測期間中にアルブミン賦形剤世界市場レポートにおいて最も急成長する地域となる見込みです。アルブミン賦形剤市場レポートの対象地域は、アジア太平洋、西欧、東欧、北米、南米、中東・アフリカです。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 マクロ経済シナリオ

• 高インフレが市場に与える影響
• ウクライナ・ロシア戦争が市場に与える影響
• COVID-19による市場への影響

第5章 世界市場規模と成長

• 世界の市場促進要因と抑制要因
  • 市場促進要因
  • 市場抑制要因
• 世界の市場規模実績と成長、2018年～2023年
• 世界の市場規模予測と成長、2023年～2028年、2033年

第6章 市場セグメンテーション

• 世界のアルブミン賦形剤市場、製品別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
• ヒト血清アルブミン
• 組換えアルブミン
• 世界のアルブミン賦形剤市場、エンドユーザー別セグメンテーション、実績および予測、2018-2023、2023-2028年、2033年
• 製薬およびバイオテクノロジー産業
• 研究機関
• その他のエンドユーザー

第7章 地域および国の分析

• 世界のアルブミン賦形剤市場、地域別、実績および予測、2018-2023、2023-2028年、2033年
• 世界のアルブミン賦形剤市場、国別、実績および予測、2018-2023、2023-2028年、2033年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• アルブミン賦形剤市場の競合情勢
• アルブミン賦形剤市場の企業プロファイル
  • Albumin Therapeutics LLC
  • Biotest AG
  • CSL Behring
  • Grifols SA
  • HiMedia Laboratories LLC

第31章 競合ベンチマーキング

第32章 競合ダッシュボード

第33章 主要な合併と買収

第34章 将来の見通しと可能性の分析

第35章 付録

“Albumin Excipient Global Market Report 2024 ” from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on albumin excipient market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
• Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
• Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
• Measure the impact of high global inflation on market growth.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for albumin excipient? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? “The albumin excipient market global report ” from The Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

Scope

Markets Covered:

• 1) By Product: Human Serum Albumin; Recombinant Albumin
• 2) By End-Users: Pharmaceutical And Biotechnology Industry; Research Institutes; Other End Users
• Companies Mentioned: Albumin Therapeutics LLC; Biotest AG;CSL Behring; Grifols S.A.;HiMedia Laboratories LLC
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Executive Summary

Albumin excipient refers to a protein derived from blood, serving as an inactive ingredient in pharmaceutical formulations. As an excipient, it functions as a carrier or stabilizer for the active pharmaceutical ingredient.

The primary product types of albumin excipients include human serum albumin and recombinant albumin. Human serum albumin, the principal protein synthesized by the liver and found in human plasma, is a key component. These albumin excipients find applications across various end-users, including the pharmaceutical and biotechnology industry, research institutes, and other related fields.

The albumin excipient market research report is one of a series of new reports from The Business Research Company that provides albumin excipient market statistics, including albumin excipient industry global market size, regional shares, competitors with an albumin excipient market share, detailed albumin excipient market segments, market trends and opportunities, and any further data you may need to thrive in the albumin excipient industry. This albumin excipient market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The albumin excipient market size has grown strongly in recent years. It will grow from $4.56 billion in 2023 to $4.91 billion in 2024 at a compound annual growth rate (CAGR) of 7.6%. The growth observed in the historical period can be attributed to several factors, including the expansion of the biopharmaceutical industry, an increased adoption of biologics, a higher prevalence of chronic diseases, advancements in clinical practices and drug innovation, and a heightened focus on drug delivery.

The albumin excipient market size is expected to see strong growth in the next few years. It will grow to $6.32 billion in 2028 at a compound annual growth rate (CAGR) of 6.5%. The anticipated growth in the forecast period can be attributed to the sustained expansion of the biopharmaceutical industry, an increasing pipeline of biologics, a rise in the geriatric population, global initiatives for vaccination, and escalating investments in drug development. Key trends expected in the forecast period encompass properties such as biodegradability and biocompatibility, collaborative efforts and partnerships in research, adherence to regulatory compliance and quality standards, applications in cell therapy, as well as a focus on customization and tailored solutions.

The increase in the prevalence of chronic diseases is poised to drive the growth of the albumin excipient market in the future. Chronic diseases, characterized by lasting three months or more and potentially worsening over time, are becoming more prevalent. Albumin, recognized as the most abundant circulating protein in plasma, serves as a blood volumizer and plays a crucial role in the treatment of various diseases, including cancer and diabetes. Its versatile nature makes it an ideal protein carrier for drug targeting, contributing to the enhancement of the pharmacokinetic profile of peptide or protein-based drugs. As per January 2023 data from The National Center for Biotechnology Information, a US-based National Library of Medicine operated by the federal government, the number of individuals in the USA aged 50 and older with at least one chronic condition is projected to increase by 99.5%, rising from 71.522 million in 2020 to 142.66 million by 2050. Therefore, the escalating prevalence of chronic diseases is a key driver behind the growth of the albumin excipient market.

The increase in healthcare expenditures is also expected to significantly contribute to the expansion of the albumin excipient market in the foreseeable future. Healthcare expenditures encompass all costs related to providing health services, family planning activities, nutrition programs, and emergency assistance with a primary focus on health. The upward trajectory of healthcare expenditures positively influences the albumin excipient market, providing substantial financial support for the development and utilization of advanced albumin-based formulations in pharmaceuticals and biopharmaceuticals. As reported in June 2023 by the Centers for Medicare & Medicaid Services, a US-based federal agency, healthcare expenditure in the United States witnessed a 2.7% increase, reaching a total of $4.3 trillion, equivalent to $12,914 per person in 2021. This accounted for 18.3% of the nation's gross domestic product. Therefore, the rise in healthcare expenditures emerges as a significant factor driving the growth of the albumin excipient market.

The adoption of product innovations is a prominent trend gaining traction in the albumin excipient market, with major companies introducing inventive solutions to maintain their positions. For instance, in November 2021, Grifols, S.A., a Spain-based healthcare company, launched ALBUTEIN FlexBag (Albumin [Human] U.S.P.) in 5% and 25% concentrations, providing healthcare professionals with a more convenient option. The 5% concentration received approval from the U.S. Food and Drug Administration (FDA) in July 2021, featuring 250 mL and 500 mL bags, while the 25% concentration, approved earlier in the year, offers 50 mL and 100 mL bags. ALBUTEIN FlexBag is available in various sizes and presented in an eco-friendly bag without plasticizers, providing a sustainable choice for healthcare professionals.

Major companies in the albumin excipient market are also engaging in collaborations to foster new relationships and jointly develop innovative medicines. In June 2023, Albumedix Ltd., a UK-based pharmaceutical company, expanded its collaboration with Valneva SE to include Valneva's newly approved inactivated COVID-19 vaccine, VLA2001. This collaboration aims to address significant unmet medical needs, with Albumedix's rHA making a substantial contribution to the vaccine's manufacturing process. Valneva SE, a France-based biotech company, specializes in the development, manufacturing, and commercialization of prophylactic vaccines for infectious diseases, including VLA2001, the only whole virus, inactivated, adjuvanted vaccine candidate in clinical trials against COVID-19 in Europe.

In September 2022, Sartorius AG, a Germany-based pharmaceutical and laboratory equipment manufacturer, made a strategic acquisition by purchasing Albumedix for $503 million. This acquisition strengthens Sartorius Inc.'s cell culture media business by expanding its portfolio of bioprocess solutions. This strategic move enhances Sartorius Inc.'s capabilities and market presence in the rapidly evolving field of bioprocessing. Albumedix, a UK-based company, focuses on the development and manufacturing of recombinant human albumin products, contributing to the advancement of biopharmaceuticals.

Major companies operating in the albumin excipient market report are Albumin Therapeutics LLC,Biotest AG,CSL Behring,Grifols S.A.,HiMedia Laboratories LLC,InVitria Inc.,Medxbio Pte Ltd.,Octapharma AG,RayBiotech Inc.,SeraCare Life Sciences Inc.,Sigma-Aldrich Pty. Ltd., Hualan Biological Engineering Inc.,Kedrion Biopharma,LFB USA Inc.,Shanghai RAAS Blood Products Co. Ltd.,Baxter International Inc.,Bristol-Myers Squibb Company,Merck KGaA,Thermo Fisher Scientific Inc.,Albumedix A/S, Bio Products Laboratory Ltd.,Shire Plc.,Ventria Bioscience Inc.,Novartis AG,China Biologic Products Holdings Inc.,ProMetic Life Sciences Inc.,Sanquin,Biopharma,Takeda Pharmaceutical Company Limited,FUJIFILM Irvine Scientific Inc.

North America was the largest region in the Albumin Excipient market in 2023. Asia-Pacific is expected to be the fastest-growing region in the global albumin excipient market report during the forecast period. The regions covered in the albumin excipient market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the albumin excipient market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The albumin excipient market consists of sales of ovalbumin, and bovine serum albumin. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Table of Contents

1. Executive Summary

2. Albumin Excipient Market Characteristics

3. Albumin Excipient Market Trends And Strategies

4. Albumin Excipient Market - Macro Economic Scenario

• 4.1. Impact Of High Inflation On the Market
• 4.2. Ukraine-Russia War Impact On the Market
• 4.3. COVID-19 Impact On the Market

5. Global Albumin Excipient Market Size and Growth

• 5.1. Global Albumin Excipient Market Drivers and Restraints
  • 5.1.1. Drivers Of The Market
  • 5.1.2. Restraints Of The Market
• 5.2. Global Albumin Excipient Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
• 5.3. Global Albumin Excipient Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Albumin Excipient Market Segmentation

• 6.1. Global Albumin Excipient Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Human Serum Albumin
• Recombinant Albumin
• 6.2. Global Albumin Excipient Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Pharmaceutical and Biotechnology Industry
• Research Institutes
• Other End Users

7. Albumin Excipient Market Regional And Country Analysis

• 7.1. Global Albumin Excipient Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 7.2. Global Albumin Excipient Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Albumin Excipient Market

• 8.1. Asia-Pacific Albumin Excipient Market Overview
• Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Albumin Excipient Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 8.3. Asia-Pacific Albumin Excipient Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Albumin Excipient Market

• 9.1. China Albumin Excipient Market Overview
• 9.2. China Albumin Excipient Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
• 9.3. China Albumin Excipient Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Albumin Excipient Market

• 10.1. India Albumin Excipient Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 10.2. India Albumin Excipient Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Albumin Excipient Market

• 11.1. Japan Albumin Excipient Market Overview
• 11.2. Japan Albumin Excipient Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 11.3. Japan Albumin Excipient Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Albumin Excipient Market

• 12.1. Australia Albumin Excipient Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 12.2. Australia Albumin Excipient Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Albumin Excipient Market

• 13.1. Indonesia Albumin Excipient Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 13.2. Indonesia Albumin Excipient Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Albumin Excipient Market

• 14.1. South Korea Albumin Excipient Market Overview
• 14.2. South Korea Albumin Excipient Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 14.3. South Korea Albumin Excipient Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Albumin Excipient Market

• 15.1. Western Europe Albumin Excipient Market Overview
• 15.2. Western Europe Albumin Excipient Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 15.3. Western Europe Albumin Excipient Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Albumin Excipient Market

• 16.1. UK Albumin Excipient Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 16.2. UK Albumin Excipient Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Albumin Excipient Market

• 17.1. Germany Albumin Excipient Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 17.2. Germany Albumin Excipient Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Albumin Excipient Market

• 18.1. France Albumin Excipient Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 18.2. France Albumin Excipient Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Albumin Excipient Market

• 19.1. Italy Albumin Excipient Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 19.2. Italy Albumin Excipient Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Albumin Excipient Market

• 20.1. Spain Albumin Excipient Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 20.2. Spain Albumin Excipient Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Albumin Excipient Market

• 21.1. Eastern Europe Albumin Excipient Market Overview
• 21.2. Eastern Europe Albumin Excipient Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 21.3. Eastern Europe Albumin Excipient Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Albumin Excipient Market

• 22.1. Russia Albumin Excipient Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 22.2. Russia Albumin Excipient Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Albumin Excipient Market

• 23.1. North America Albumin Excipient Market Overview
• 23.2. North America Albumin Excipient Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 23.3. North America Albumin Excipient Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Albumin Excipient Market

• 24.1. USA Albumin Excipient Market Overview
• 24.2. USA Albumin Excipient Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 24.3. USA Albumin Excipient Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Albumin Excipient Market

• 25.1. Canada Albumin Excipient Market Overview
• 25.2. Canada Albumin Excipient Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 25.3. Canada Albumin Excipient Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Albumin Excipient Market

• 26.1. South America Albumin Excipient Market Overview
• 26.2. South America Albumin Excipient Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 26.3. South America Albumin Excipient Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Albumin Excipient Market

• 27.1. Brazil Albumin Excipient Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 27.2. Brazil Albumin Excipient Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Albumin Excipient Market

• 28.1. Middle East Albumin Excipient Market Overview
• 28.2. Middle East Albumin Excipient Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 28.3. Middle East Albumin Excipient Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Albumin Excipient Market

• 29.1. Africa Albumin Excipient Market Overview
• 29.2. Africa Albumin Excipient Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 29.3. Africa Albumin Excipient Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Albumin Excipient Market Competitive Landscape And Company Profiles

• 30.1. Albumin Excipient Market Competitive Landscape
• 30.2. Albumin Excipient Market Company Profiles
  • 30.2.1. Albumin Therapeutics LLC
    • 30.2.1.1. Overview
    • 30.2.1.2. Products and Services
    • 30.2.1.3. Strategy
    • 30.2.1.4. Financial Performance
  • 30.2.2. Biotest AG
    • 30.2.2.1. Overview
    • 30.2.2.2. Products and Services
    • 30.2.2.3. Strategy
    • 30.2.2.4. Financial Performance
  • 30.2.3. CSL Behring
    • 30.2.3.1. Overview
    • 30.2.3.2. Products and Services
    • 30.2.3.3. Strategy
    • 30.2.3.4. Financial Performance
  • 30.2.4. Grifols S.A.
    • 30.2.4.1. Overview
    • 30.2.4.2. Products and Services
    • 30.2.4.3. Strategy
    • 30.2.4.4. Financial Performance
  • 30.2.5. HiMedia Laboratories LLC
    • 30.2.5.1. Overview
    • 30.2.5.2. Products and Services
    • 30.2.5.3. Strategy
    • 30.2.5.4. Financial Performance

31. Global Albumin Excipient Market Competitive Benchmarking

32. Global Albumin Excipient Market Competitive Dashboard

33. Key Mergers And Acquisitions In The Albumin Excipient Market

34. Albumin Excipient Market Future Outlook and Potential Analysis

• 34.1 Albumin Excipient Market In 2028 - Countries Offering Most New Opportunities
• 34.2 Albumin Excipient Market In 2028 - Segments Offering Most New Opportunities
• 34.3 Albumin Excipient Market In 2028 - Growth Strategies
  • 34.3.1 Market Trend Based Strategies
  • 34.3.2 Competitor Strategies

35. Appendix

• 35.1. Abbreviations
• 35.2. Currencies
• 35.3. Historic And Forecast Inflation Rates
• 35.4. Research Inquiries
• 35.5. The Business Research Company
• 35.6. Copyright And Disclaimer